• #1047522
  • 334
  • Glaxo Smith Kline #58160097620

Bexsero® Meningitis Vaccine For Individuals 10 Through 25 Years of Age Meningococcal Group B Vaccine 50 mcg - 50 mcg / 0.5 mL Injection Prefilled Syringe 10 Syringes

BEXSERO, PFS 0.5ML (10/BX) RX

Features
  • BEXSERO is a vaccine indicated for active immunization to prevent invasive disease caused by Neisseria meningitidis serogroup B
  • BEXSERO is approved for use in individuals 10 through 25 years of age
  • BEXSERO is supplied as a 0.5 mL suspension in a glass pre-filled syringe
  • More …
  Log In to Order
or

Product Specifications


McKesson #1047522
Manufacturer #58160097620
BrandBexsero®
ManufacturerGlaxo Smith Kline
Country of OriginUnknown
Alternate Manufacturer Number3605193
ApplicationMeningitis Vaccine
Container TypePrefilled Syringe
Dosage FormInjection
Generic Drug Code35944
Generic Drug NameMeningococcal Group B Vaccine
NDC Number58160097620
Product DatingMcKesson Acceptable Dating: we will ship >= 90 days
Storage RequirementsRequires Refrigeration
Strength50 mcg - 50 mcg / 0.5 mL
TypeIntramuscular
UNSPSC Code51201610
UserFor Individuals 10 Through 25 Years of Age
Volume10 Syringes
Features
  • BEXSERO is a vaccine indicated for active immunization to prevent invasive disease caused by Neisseria meningitidis serogroup B
  • BEXSERO is approved for use in individuals 10 through 25 years of age
  • BEXSERO is supplied as a 0.5 mL suspension in a glass pre-filled syringe
More Information

Professionals Also Viewed